International Journal of Molecular Sciences Article Remodeling of Kv7.1 and Kv7.5 Expression in Vascular Tumors Clara Serrano-Novillo 1 , Anna Oliveras 1 , Joan Carles Ferreres 2 , Enric Condom 3 and Antonio Felipe 1,4, * 1 Molecular Physiology Laboratory, Department de Bioquímica i Biomedicina Molecular, Institut de Biomedicina (IBUB), Universitat de Barcelona, 08028 Barcelona, Spain; clara.serrano.n@gmail.com (C.S.-N.); aolivema@gmail.com (A.O.) 2 Consorci Corporació Sanitària Parc Taulí-Parc Taulí Hospital Universitari, Universitat Autónoma de Barcelona, 08208 Sabadell, Spain; joancfp@gmail.com 3 Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Hospital Universitari de Bellvitge, 08907 L’Hospitalet de Llobregat, Spain; ecm@bellvitgehospital.cat 4 Departament de Bioquímica i Biomedicina Molecular, Universitat de Barcelona, Avda. Diagonal 643, 08028 Barcelona, Spain * Correspondence: afelipe@ub.edu; Tel.: +34-934034616; Fax: +34-934021559  Received: 27 July 2020; Accepted: 18 August 2020; Published: 21 August 2020  Abstract: Voltage-dependent potassium (Kv) channels contribute to the excitability of nerves and muscles. In addition, Kv participates in several cell functions, including cell cycle progression and proliferation. Kv channel remodeling has been associated with neoplastic cell growth and cancer. Kv7 channels are expressed in blood vessels, and they participate in the maintenance of vascular tone and are implicated in myocyte proliferation. Although evidence links Kv7 remodeling to different types of cancer, its expression in vascular tumors has never been studied. Endothelium-derived vascular neoplasms range from indolent lesions to highly aggressive and metastasizing cancers. Here, we show that Kv7.1 and Kv7.5 are evenly distributed in tunicas as well as the endothelium of healthy veins and arteries. The layered structure of vessels is lost in vascular tumors. By studying eight vascular tumors with different origins and characteristics, we found that Kv7.1 and Kv7.5 expression was changed in vascular cancers. While both channels were generally downregulated, Kv7.5 expression was clearly correlated with neoplastic malignancy. The vascular tumors did not contract; therefore, the role of Kv7 channels is probably related to proliferation rather than controlling vascular tone. Our results identify vascular Kv7 channels as targets for cancer detection and anticancer therapies. Keywords: potassium channels; blood vessels; neoplasia; cancer 1. Introduction Voltage-dependent potassium channels (Kv) control the action potential of nerves and muscles. In addition, Kv channels contribute to the membrane potential by participating in the electrochemical gradient. Furthermore, changes in the membrane potential are crucial during cell cycle progression and proliferation. Therefore, Kv channels are actively involved in physiological and neoplastic cell proliferation [1–4]. Vascular tumors result from the pathological proliferation of vascular endothelial cells with variable growth capacity. Healthy blood vessels organize in stratified cell layers named tunica. While tunica media mainly contains smooth muscle, the endothelium forms the tunica intima. Endothelial tumors, which are heterogenous in both histology and behavior, are classified as malformations or neoplasms Int. J. Mol. Sci. 2020, 21, 6019; doi:10.3390/ijms21176019 www.mdpi.com/journal/ijms Int. J. Mol. Sci. 2020, 21, 6019 2 of 13 depending on the presumed origin of the malignancy. Many tumors undergo spontaneous involution, others proliferate and become static, and a small subset are locally aggressive and metastasize [5,6]. Potassium channels from the Kv7 family participate in the maintenance of vascular tone. While Kv7 channel activators trigger vasodilation, inhibitors contract vessels [7]. The Kv7 family consists of five members (Kv7.1–Kv7.5), which generate outward delayed rectifying potassium currents and have a central role in regulating cell excitability. Kv7.1, Kv7.4 and Kv7.5 are expressed in vascular smooth muscle. Kv7.4 and Kv7.5 participate in the contractility of vascular cells [7]. Additionally, PKC (protein kinase C) suppresses Kv7.5 currents upon vessel constriction in rat aortas or mesenteric arteries. This depolarizes the membrane, opening Ca2+ channels and promoting muscle contraction [8]. In addition, Kv7.4, alone or in heterotetramers with Kv7.5, contributes to vasodilation [9]. Moreover, a variety of veins and arteries express Kv7.1, suggesting a possible role in smooth muscle contraction [10]. However, the contribution of Kv7.1 is an open debate. Outward K+ currents are linked to Kv7.1 in murine veins [11] and its expression has been confirmed in human arteries; however, Kv7.1 antagonist treatment did not alter vascular tone [12]. Evidence attributes the absence of Kv7.1 functions to the presence of auxiliary KCNE subunits, such as KCNE4 and KCNE5, which inhibit Kv7.1 currents and are often coexpressed with the channel in blood vessels [13]. Another possibility is the heterotetramerization of the channel. Kv7.1 associates with Kv7.5 in vascular myocytes, which alters the biophysical properties of the channel [14]. As mentioned above, Kv channels participate in regulating membrane potential, and they facilitate cell cycle progression to promote cell growth [1–3]. Thus, Kv7.1 and Kv7.5 are implicated in myocyte proliferation. Kv7.1 is remodeled in some tumors and Kv7.5 blockers halt proliferation. Kv7.1 increases in colon cancer and lung adenocarcinoma as well as in seminoma and other germ cell tumors [15–17]. On the other hand, even though Kv7.5 contributes to myoblast proliferation [18] and vascular physiology, it has not been studied in tumors other than osteosarcoma [19]. In the present work, we studied different vascular and perivascular tumors categorized as benign, intermediate and malignant. Tumors were histologically classified according to the 5th edition of the World Health Organization (WHO) classification of soft tissue tumors [20]. The samples are from the following types: angioma, glomus tumor, Kaposi’s sarcoma, epithelioid haemangioendothelioma and angiosarcoma. Following WHO classification, angiomas were categorized as either benign endothelial neoplasms or malformative lesions, which are often present at birth. Kaposi’s sarcoma is a locally aggressive neoplasia. Epithelioid haemangioendothelioma and angiosarcoma are fully malignant tumors with a high proliferative index. Our data show that while Kv7.1 expression is mostly downregulated with no apparent correlation with tumor aggressiveness, the expression of Kv7.5 is correlated with malignancy. 2. Results 2.1. Expression of Kv7.1 and Kv7.5 in Human Blood Vessels Members of the Kv7 family are mainly expressed in nerves and muscles. While Kv7.1 has a critical role in heart physiology, Kv7.5 contributes to the neuronal M-current [21]. The channels are similarly regulated during muscle proliferation, and they both exhibit human cardiovascular smooth muscle vessel expression (Figure 1). Thus, Kv7.1 and Kv7.5 are differentially expressed in arteries (aorta and carotid) and veins (inferior vena cava and subclavian). Based on these results, Kv7.5 seems more abundant in arteries than veins. Rat brain, heart and skeletal muscle were used as positive controls. Slight differences in molecular weight were observed due to isoform variabilities between tissues and species (Figure 1A). Int. J. Mol. Sci. 2020, 21, 6019 3 of 13 Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 3 of 13 Figure 1. Voltage-dependent Figure 1. Voltage-dependentpotassium potassium (Kv)7.1 (Kv)7.1 andand Kv7.5 Kv7.5 are differentially are differentially expressed expressed in human in human blood blood vessels. (A) Membrane protein extracts were obtained from several human vessels. (A) Membrane protein extracts were obtained from several human blood vessels (aorta blood vessels (aorta and and carotid carotid arteries arteries and inferior and inferior cavasubclavian cava and and subclavian veins)veins) and ratand rat samples tissue tissue samples (brain, skeletal (brain, skeletal muscle muscle and(B and heart). heart). (B Fresh and C) and C) Fresh samples human human samples were obtained were obtained and processed and processed as describedas described in the in the Materials Materials and Methods. and Methods. Sections Sections were werewith stained stained with anti-Kv7.1 anti-Kv7.1 (B) or anti-Kv7.5 (B) or anti-Kv7.5 (C) antibodies. (C) antibodies. Then, Then, α-actin α-actin was used to identify muscle structures. Red, Kv7.1 (B) and Kv7.5 (C) channels; green, was used to identify muscle structures. Red, Kv7.1 (B) and Kv7.5 (C) channels; green, α-actin; merge, α-actin; merge, superimposed superimposed channel,channel, α-actin α-actin and nuclear and nuclear DAPI staining DAPI staining (in TI: (in blue). blue). TI: intima; tunica tunica intima; TM: TM: tunica tunica media; TE: tunica externa; e: endothelial layer; se: subendothelial layer. Scale bars: media; TE: tunica externa; e: endothelial layer; se: subendothelial layer. Scale bars: 50 µm in cava and 50 μm in cava and subclavian subclavian veins; 100veins; µm in100 μm in carotid carotid artery; 250artery; µm in250 μmartery. aorta in aorta artery. 2.2. Kv Channel Expression Histological in Vascular analysis and Tumors fluorescent staining of human veins and arteries further supported Kv7.1 and Kv7.5 expression in blood vessels (Figure 1B,C). However, the staining was not evenly distributed, Twenty-seven cases of eight different vascular tumors were initially divided into two groups as demonstrated by α-actin results. Although both channels are expressed in the tunica media vascular depending on the specimen preparation. Then, paraffin-embedded and optimal cutting temperature smooth muscle in both veins and arteries, the signal was more intense in the endothelium within compound (OCT) samples were analyzed. The paraffin-embedded group contained cavernous the tunica intima. Negative control experiments, performed in all cases, demonstrated that channel angioma, capillary angioma, Kaposi’s sarcoma, angiosarcoma and glomus tumors. The first four are staining was specific (Figure S1 (Supplementary Materials)). derived from endothelial cells and exhibit different grades of malignancy, from benign or indolent to highly 2.2. Kv malignant. Glomusintumors Channel Expression Vascularare derived from modified smooth muscle cells of the normal Tumors glomus body (glomus cells) surrounding the vessel walls. The OCT-embedded group included three Twenty-seven malignant, highly cases of eightand metastatic different very vascular tumors cutaneous rare tumors: were initially divided into two angiosarcoma, groups epithelioid depending on the specimen preparation. Then, paraffin-embedded and optimal cutting hemangioendothelioma and testicular teratoma-derived angiosarcoma. Because neoplasms of these temperature compound types (OCT) are rare, thesamples sample were analyzed. availability wasThe veryparaffin-embedded groupnecessary limited but considered containedto cavernous provide angioma, essential information. Considering the distinct process required because of their different embedding derived capillary angioma, Kaposi’s sarcoma, angiosarcoma and glomus tumors. The first four are and the from endothelial limitation cellsfor of samples andthe exhibit different analysis of the grades of malignancy, OCT-embedded from tumors, thebenign or indolent two groups to highly were analyzed malignant. Glomus tumors are derived from modified smooth muscle cells of the normal glomus body separately. (glomus cells) surrounding Paraffin-embedded the vessel samples werewalls. The OCT-embedded stained group included with hematoxylin-eosin three amalignant, to enable detailed highly metastatic and very rare tumors: cutaneous morphological evaluation (Figure 2(Aa,Ba,Ca,Da,Ea,Fa)). angiosarcoma, epithelioid hemangioendothelioma Int. J. Mol. Sci. 2020, 21, 6019 4 of 13 and testicular teratoma-derived angiosarcoma. Because neoplasms of these types are rare, the sample availability was very limited but considered necessary to provide essential information. Considering Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 4 of 13 the distinct process required because of their different embedding and the limitation of samples for the analysis of the OCT-embedded tumors, the two groups were analyzed separately. Cavernous haemangioma (Cv) is a benign vascular lesion that is often a malformation in origin Paraffin-embedded samples were stained with hematoxylin-eosin to enable a detailed (Figure 2Aa). This representative specimen presented a sponge-like appearance due to dilated and morphological evaluation (Figure 2Aa,Ba,Ca,Da,Ea,Fa). congestive vessels lined by flattened endothelial cells with no visible muscle layer. Figure 2. Kv7.1 Kv7.1 and and Kv7.5 Kv7.5 expression expression in in paraffin-embedded paraffin-embedded vascular tumors. Consecutive sections of vascular tumor samples were stained with hematoxylin-eosin (HE) and were immunofluorescently labeled for Kv7.1 and Kv7.5. (Aa–Ae) Cavernous angioma. (Ba–Be) Capillary hemangioma. (Ca–Ce) (Ca–Ce) Kaposi’s sarcoma. (Da–De) (Da–De) Angiosarcoma. Angiosarcoma. (Ea–Ee) (Ea–Ee) Glomus Glomus tumor. tumor. HE HEwaswas used used to to identify structures. BV: BV:healthy healthy blood vessels; blood *: tumoral vessels; bloodblood *: tumoral vessels. Scale bars: vessels. Scale50 bars: μm, capillary 50 µm, angioma; capillary angioma; 100 cavernous angioma, Kaposi’s sarcoma and angiosarcoma; 100 μm, cavernous angioma, Kaposi’s sarcoma and angiosarcoma; 200 μm, glomus tumor. µm, 200 µm, glomus tumor. Representative immunolabeling Representative immunolabelingimages imagesshowing showingmerged Kv7.1 merged in healthy Kv7.1 (Ab,Bb,Cb,Db,Eb) in healthy and tumor (Ab,Bb,Cb,Db,Eb) and (Ac,Bc,Cc,Dc,Ec) tumor biopsies. (Ac,Bc,Cc,Dc,Ec) Representative biopsies. immunolabeling Representative images images immunolabeling showing mergedmerged showing Kv7.5 inKv7.5 healthy in (Ad, Bd,(Ad, healthy Cd, Dd, Bd, Ed) Cd, and Dd, tumor Ed) and(Ae,Be,Ce,De,Ee) biopsies. biopsies. tumor (Ae,Be,Ce,De,Ee) Red, channels; green, α-actin Red, channels; green,(muscle); α-actin blue, DAPIblue, (muscle); nuclear DAPIstaining; gray, nuclear far red gray, staining; detection of red far red blood cells detection of showing red bloodhigh autofluorescence cells showing high Scale bars: 100 µm in cavernous and capillary angioma; 80 µm in Kaposi’s sarcoma, angiosarcoma autofluorescence Scale bars: 100 μm in cavernous and capillary angioma; 80 μm in Kaposi’s sarcoma, and glomus tumor.and glomus tumor. angiosarcoma Cavernous Lobular haemangioma capillary (Cv) is(Cp) haemangioma a benign vascular is a reactive lesion that vascular is that lesion oftenmostly a malformation appears inin origin the skin (Figure 2Aa). This representative specimen presented a sponge-like appearance due to dilated or mucosal surfaces (Figure 2Ba). This indolent nonneoplastic lesion was made of small capillary-like and congestive vessels lined by flattened endothelial cells with no visible vessels arising from larger vessels, and it exhibited a lobular appearance. muscle layer. Kaposi’s sarcoma (KS), mostly located in the dermis (Figure 2Ca), grew as fascicles of spindle cells; there was a prominent surrounding haemorrhage and small slit-like spaces containing erythrocytes. Angiosarcoma (As) is a malignant neoplasia arising from the endothelial cells lining blood or lymphatic vessels (Figure 2Da). This highly aggressive and proliferative sample was subcutaneous and exhibited many mitotic cells. Spindle and epithelioid atypical cells formed solid masses or Int. J. Mol. Sci. 2020, 21, 6019 5 of 13 Lobular capillary haemangioma (Cp) is a reactive vascular lesion that mostly appears in the skin or mucosal surfaces (Figure 2Ba). This indolent nonneoplastic lesion was made of small capillary-like vessels arising from larger vessels, and it exhibited a lobular appearance. Kaposi’s sarcoma (KS), mostly located in the dermis (Figure 2Ca), grew as fascicles of spindle cells; there was a prominent surrounding haemorrhage and small slit-like spaces containing erythrocytes. Angiosarcoma (As) is a malignant neoplasia arising from the endothelial cells lining blood or lymphatic vessels (Figure 2Da). This highly aggressive and proliferative sample was subcutaneous and exhibited many mitotic cells. Spindle and epithelioid atypical cells formed solid masses or bundles, and there were irregular and anastomosing cavities containing red blood cells. There was marked cytological atypia and pleomorphism with a high mitotic index. Glomus tumor (GT) is a rare indolent neoplasm located in the dermis (Figure 2Ea). This tumor does not originate from endothelial cells but from glomus cells, which are a type of a modified smooth muscle cell with thermoregulatory function. Tumors grew as nodules and contained blood vessels. Kv7.1 and Kv7.5 staining was studied in the tumors (Figure 2Ab–Ee). Confocal microscopy imaging at low magnification was used to obtain an image of the whole sample. Next, several nontumor and tumor areas within the same sample were identified using a screening system. As mentioned above, the blood vessel endothelium expressed Kv7.1 and Kv7.5 in healthy vessels with a normal layer structure. Channel staining within the tumor areas was consistently disorganized. Neoplastic vessels showed no layers. To evaluate changes caused by neoplastic transformation, healthy expression was compared to affected areas. Kv7.1 and Kv7.5 expression levels were calculated from their fluorescence intensity in healthy and tumor areas from each specimen. Channel expression levels from different individuals revealed high variability among patients. Therefore, the data were normalized, and the relative expression was compared (Figure S2 (Supplementary Materials)). Because intrinsic patient variability in healthy areas arose from different types of analyzed vessels, including veins and arteries, both were considered. However, the staining was uniform in tumor areas. Our data revealed that Kv7.5, and Kv7.1 to a greater extent, exhibited decreased expression in vascular tumors. The tumor-to-normal ratio (TN ratio) was calculated (Figure 3). This index represented the relation between the expression in tumors and the expression in healthy areas. Ratios above one indicated an increase in expression, whereas ratios below one corresponded to a downregulation of the channel in cancerous areas. Data confirmed that Kv7.1 and Kv7.5 were remodeled in human vascular tumors. Kv7.1 showed significant changes (Figure 3A). TN ratios were similar, with a 30–40% reduction in all tumors. While glomus tumors appeared to be very homogeneous, cavernous angiomas were highly heterogeneous. Unlike Kv7.1, Kv7.5 exhibited variability among tumors (Figure 3B). Although the overall results showed downregulation of Kv7.5, only the changes in capillary and cavernous angioma and glomus tumors were significant. Interestingly, malignant KS and angiosarcoma exhibited only minor Kv7.5 changes. In contrast, angiomas, which are sometimes considered vascular malformations rather than neoplasms, exhibited consistently lower Kv7.5 expression. Neoplastic vessels were also analyzed. However, changes in Kv expression were not related to any anatomical and histological features of tumor vessels. Thus, no correlation between the size/shape of the neoangiogenic vessels and Kv7.1 or Kv7.5 alterations was found (data not shown). Together, our data demonstrated that Kv7.1 and Kv7.5 remodeled expression during vascular neoplastic changes, mainly through exhibiting reduced expression. The second group of tumors studied included OCT frozen samples from the following malignant rare blood vessel tumors: cutaneous angiosarcoma, epithelioid haemangioendothelioma and angiosarcoma derived from a highly proliferative and aggressive testicular teratoma. These cancers are characterized as the most malignant group of vascular tumors. The OCT samples were also stained with hematoxylin-eosin to enable identification of their main histological features (Figure 4Aa,Ba,Ca). angiomas were highly heterogeneous. Unlike Kv7.1, Kv7.5 exhibited variability among tumors (Figure 3B). Although the overall results showed downregulation of Kv7.5, only the changes in capillary and cavernous angioma and glomus tumors were significant. Interestingly, malignant KS and angiosarcoma exhibited only minor Kv7.5 changes. In contrast, angiomas, which are sometimes considered Int. vascular J. Mol. Sci. 2020, 21, 6019malformations rather than neoplasms, exhibited consistently lower Kv7.5 6 of 13 expression. Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 6 of 13 Neoplastic vessels were also analyzed. However, changes in Kv expression were not related to any anatomical and histological features of tumor vessels. Thus, no correlation between the size/shape of the neoangiogenic vessels and Kv7.1 or Kv7.5 alterations was found (data not shown). Figureour Together, Figure 3. Tumor-to-normal 3. Tumor-to-normal data demonstrated (TN)Kv7.1 (TN) Kv7.1 and that and Kv7.5 Kv7.1 Kv7.5 andratios. Kv7.5 ratios. TN ratios TN ratios were calculated remodeled were calculated expressionas described as described duringin invascular the the Materials neoplastic Materials and Methods changes, and Methods mainlyfrom from protein through protein expression exhibiting expression levels in reduced levels in immunofluorescence assays, expression. immunofluorescence assays, and and the the data data are represented in a box-and-whisker plot. The analysis was performed The second group of tumors studied included OCT frozen samples from the following malignant are represented in a box-and-whisker plot. The analysis was performed for for Kv7.1 Kv7.1 (A) (A) and and Kv7.5 Kv7.5 (B). (B). The rare The blood reference reference value vesselvalue (1) is indicated (1) is indicated tumors: cutaneous by a dotted vertical by a angiosarcoma, dotted vertical line.line. Boxes represent Boxes represent epithelioid the interquartile range the interquartile range and haemangioendothelioma (IQR: 25–75%) (IQR: angiosarcoma 25–75%) of the of derived the values. values. from The inside-box The a highly inside-box line represents line proliferative represents the mean the and aggressive mean ofeach of eachgroup. testicular group. teratoma. Minimum Minimum Theseand and cancers maximum maximum values values are are indicated indicated outside outside the the box. box. Cavernous angioma, are characterized as the most malignant group of vascular tumors. The OCT samples were also in magenta; Capillary angioma, in green; Kaposi’s in stained Kaposi’s sarcoma, with hematoxylin-eosinsarcoma,ininorange; toorange;Angiosarcoma, enable Angiosarcoma, identification in in blue; ofblue;Glomus theirGlomus main tumor, in red. tumor, in red. histological p < ** * p < *0.05, features p< 0.05, (Figure 0.01 ** p < and 4(Aa,Ba,Ca)).0.01 *** andp <*** 0.001 p < vs. reference 0.001 vs. value value reference (one sample (one t-test statistics). sample t-test statistics). Figure Figure 4. 4. Kv7.1 Kv7.1 and and Kv7.5 Kv7.5 expression expression in optimal cutting in optimal cutting temperature temperature compound compound (OCT)-embedded (OCT)-embedded malignant malignant vascular tumors. Consecutive sections of vascular tumor samples were vascular tumors. Consecutive sections of vascular tumor samples were stained stained by by hematoxylin-eosin (HE) and immunofluorescent labeling for Kv7.1 and Kv7.5. (Aa–Ac) Cutaneous hematoxylin-eosin (HE) and immunofluorescent labeling for Kv7.1 and Kv7.5. (Aa–Ac) Cutaneous angiosarcoma. (Ba–Bc) Epithelioid haemangioendothelioma. (Ca–Cc) Testicular teratoma-derived angiosarcoma. (Aa,Ba,Ca) HE was used to identify structures. BV: healthy blood vessels; *: tumoral blood vessels. Scale bars 150 μm. Representative immunolabeling images showing merged Kv7.1 (Ab,Bb,Cb) and Kv7.5 (Ac,Bc,Cc) and tumor biopsies. Red, channels; green, α-actin (muscle); blue, DAPI nuclear staining. Scale bars 150 μm. (D) Tumor-to-normal (TN) ratios, in arbitrary units, were Int. J. Mol. Sci. 2020, 21, 6019 7 of 13 angiosarcoma. (Ba–Bc) Epithelioid haemangioendothelioma. (Ca–Cc) Testicular teratoma-derived angiosarcoma. (Aa,Ba,Ca) HE was used to identify structures. BV: healthy blood vessels; *: tumoral blood vessels. Scale bars 150 µm. Representative immunolabeling images showing merged Kv7.1 (Ab,Bb,Cb) and Kv7.5 (Ac,Bc,Cc) and tumor biopsies. Red, channels; green, α-actin (muscle); blue, DAPI nuclear staining. Scale bars 150 µm. (D) Tumor-to-normal (TN) ratios, in arbitrary units, were calculated from the protein expression levels obtained in immunofluorescence assays and represented in a forest plot. The analysis was performed for Kv7.1 (top) and Kv7.5 (bottom) channels, plotted in horizontal bars. The reference value (1) is indicated by a dotted line. Squares represent the mean ± SEM of the TN ratio for each patient and tumor. Gray, cutaneous angiosarcoma. White, epithelioid haemangioendothelioma. Black, testicular teratoma-derived angiosarcoma. Mean ± SEM, only represented when multiple samples and regions of interest (ROIs) were available. Cutaneous angiosarcoma (CAs). (Figure 4Aa). Tumoral cells presented elongated nuclei and created bundles, enabling solid and infiltrative growth, that dissected the dermal collagen and subcutaneous fat. This epithelioid haemangioendothelioma (EHE) was located in the liver (Figure 4Ba). The tumor was composed of epithelioid large cells and the remaining collagenous stroma. This structure endowed the tumor with a mixed matrix composition with dense areas, containing high nuclear concentration, and paucicellular areas, containing mainly stroma. The lumen of small vessel appeared as small vacuoles in between one or two tumoral cells, and they were characterized by reduced cytoplasm and atypical nuclei. Testicular teratoma-derived angiosarcoma (TAs). This representative sample was a primary testicular angiosarcoma and mature teratoma (Figure 4Ca). Histologically similar to cutaneous angiosarcoma. Thus, this biopsy depicted a solid architectural pattern with no neoangiogenic lumens and fusiform tumoral bundles. This highly proliferative and malignant tumor contained necrotic areas. Analysis of Kv7.1 and Kv7.5 expression was performed in areas containing healthy and tumoral blood vessels (Figure 4Ab–Cc). Confocal images were captured, Kv7.1 and Kv7.5 fluorescence intensities were analyzed, and TN ratios were calculated to compare tumoral and control areas (Figure 4D). Multiple regions of interest (ROIs) were evaluated from each tumor. However, as mentioned above, tumor availability was very limited due to their extremely low prevalence. Although limited information can be obtained at this point, the TN ratios revealed minor Kv7 expression changes in most of the sections. 2.3. Kv7.1 and Kv7.5 Expression Correlates with Tumor Malignancy Kv7.1 and Kv7.5 have been linked to muscle proliferation [18], and our data demonstrated that both channels are remodeled in vascular cancers. Therefore, we next wanted to decipher whether this phenotype followed a relationship with malignancy. Tumor malignancy and mitotic index (MI) were evaluated by histological properties (Figure 5A). Because higher cell division rates are commonly associated with more malignant phenotypes, the highest MI values typically correspond with malignant rare tumors. Therefore, although the information yielded by these rare cases should be taken with caution because few samples were available, they provide qualitatively important information that accurately represent these samples (Figure 5B). MI was used to rank the tumor malignancy, and we wondered whether it had any relationship to Kv7.1 and Kv7.5 expression. TN ratios were plotted against the malignancy of tumors, and Pearson’s correlation coefficient was calculated (Figure 6). As mentioned above, indolent tumors tended to exhibit downregulated Kv7.1 and Kv7.5 expression, whereas highly proliferative tumors maintained channel levels similar to those of healthy biopsies. Thus, Kv7.5 expression, and to a lesser extent Kv7.1 expression, was tightly correlated with the clinical aggressiveness of the tumor. Pearson’s correlation coefficients were r = 0.683 (p = 0.061) and r = 0.862 (p = 0.006) for Kv7.1 and Kv7.5, respectively. Only Kv7.5 reached statistically significant values (Figure 6B), but this was mainly due to the distortion generated by a unique patient with a cavernous angioma that uniquely exhibited increased rather 2.3. Kv7.1 and Kv7.5 Expression Correlates with Tumor Malignancy Kv7.1 and Kv7.5 have been linked to muscle proliferation [18], and our data demonstrated that both channels are remodeled in vascular cancers. Therefore, we next wanted to decipher whether this phenotype Int. J. Mol. Sci.followed a relationship with malignancy. Tumor malignancy and mitotic index (MI) 8were 2020, 21, 6019 of 13 evaluated by histological properties (Figure 5A). Because higher cell division rates are commonly associated with more malignant phenotypes, the highest MI values typically correspond with than decreased Kv7.1 expression (Figure S2A (Supplementary Materials)). However, a clear difference malignant rare tumors. Therefore, although the information yielded by these rare cases should be was observed between malignant tumors, EHE, TAs and CAs, and the rest of the samples. Therefore, taken with caution because few samples were available, they provide qualitatively important higher levels of Kv7.1 and Kv7.5 expression corresponded with the malignancy of vascular tumors. information that accurately represent these samples (Figure 5B). Int. J. Mol. Sci. 2020, 21, x FOR PEER REVIEW 8 of 13 samples, gray bars indicate OCT samples. Values are represented as the mean ± SEM; p < 0.01 (one- way ANOVA). MI was used to rank the tumor malignancy, and we wondered whether it had any relationship to Kv7.1 and Kv7.5 expression. TN ratios were plotted against the malignancy of tumors, and Pearson’s correlation coefficient was calculated (Figure 6). As mentioned above, indolent tumors tended toMitotic Figure exhibit downregulated Kv7.1 and Kv7.5 expression,identified, whereas highly proliferative tumors Figure 5.5. Mitotic index index ofof tumors. tumors. Histological Histologicalpatterns patternswere were identified, and and the the mitotic mitotic index index (MI) (MI) maintained channel levels similar to those of healthy biopsies. Thus, Kv7.5 expression, and to a lesser was evaluated from the hematoxylin-eosin stained samples. samples. (A) (A) The The MI MI was calculated calculated by counting extent Kv7.1 expression, was tightly correlated with the clinical aggressiveness of the tumor. all all mitotic mitotic events present in 10 high-power fields (HPF) at at 400× 400× magnification. HPF,HPF, based based on on the Pearson’s correlation coefficients were r = 0.683 (p = 0.061) and r = 0.862 (p = 0.006) for Kv7.1 and frequency of mitosis, mitosis, wereclassified classifiedasaslow low(<2 (<2mitosis mitosisinin1010HPF), HPF), moderate(2–5 (2–5 mitosisin in 10 HPF) Kv7.5, respectively. were Only Kv7.5 reached statistically significantmoderate values (Figure mitosis 6B), but 10this HPF) wasor or highhigh (>5(>5 mitosis mitosis in in 10 10 HPF). HPF). The The % % values values indicate indicate the the percentage percentage of of mitotic mitotic cells cells mainly due to the distortion generated by a unique patient with a cavernous angioma that uniquely compared compared withwith the the totaltotal exhibited number number increasedof rather of cells cells evaluated. evaluated. OCT-frozen than OCT-frozen decreased malignant malignant Kv7.1 tumor samplessamples tumor(Figure expression are identified are (Supplementary S2A identified by a dark by a dark gray box. Materials)). gray (B) box. (B) The The MIaplotted However, MI plotted against the clear difference against wastumorthe tumor type. type. between observed Values Values from from panel panel Atumors, malignant A were were plotted plotted EHE, versus TAs and versus tumors, CAs, andtumors, and the the and rest the malignancymalignancy of the for each for samples. eachwas cancer Therefore,cancer waslevels higher determined. determined. While of Kv7.1 While white white andbars bars represent represent Kv7.5 paraffin-embedded paraffin-embedded expression corresponded samples, with the gray bars indicate malignancy tumors. Values are represented as the mean ± SEM; p < 0.01 (one-way ANOVA). OCT samples. of vascular Figure Figure 6. Kv7.1 6. Kv7.1 and and Kv7.5Kv7.5 expression expression according according to tumor to tumor malignancy.Kv7.1 malignancy. Kv7.1(A) (A)and andKv7.5 Kv7.5(B) (B)TN TNratios ratios (tumor-to-normal (tumor-to-normal ratios) ratios) plotted plotted against against their mitotictheir mitotic index index as as a marker of athemarker clinicalofaggressiveness the clinical of aggressiveness vascular tumors. AofPearson’s vascular correlation tumors. A Pearson’s correlation coefficient coefficient of r = 0.683 with pof r = 0.683 = 0.061 with p no indicates = 0.061 apparent indicates no apparent correlation between Kv7.1 expression and tumor aggressiveness. A Pearson’s correlation between Kv7.1 expression and tumor aggressiveness. A Pearson’s correlation coefficient of r correlation coefficient of r = 0.862 with p = 0.006 indicates a direct correlation between Kv7.5 = 0.862 with p = 0.006 indicates a direct correlation between Kv7.5 expression and tumor aggressiveness. expression and tumor aggressiveness. Values are the mean ± SEM. Cv: cavernous angioma; Cp: Values are the mean ± SEM. Cv: cavernous angioma; Cp: capillary angioma; GT: glomus tumor; capillary angioma; GT: glomus tumor; KS: Kaposi’s sarcoma; EHE: epithelioid KS: Kaposi’s sarcoma; EHE: epithelioid haemangioendothelioma; haemangioendothelioma; As: angiosarcoma; As: angiosarcoma; TAs: testicular teratoma-derived TAs: testicular angiosarcoma; and teratoma-derived angiosarcoma; CAs: cutaneous angiosarcoma. and CAs: cutaneous angiosarcoma. 3. Discussion 3. Discussion Kv channels areare Kv channels crucial forfor crucial thethecardiovascular system.Kv7.1 cardiovascular system. Kv7.1 and and Kv7.5 Kv7.5 participate participate in vascular in vascular smooth muscle smooth tonetone muscle in the control in the of blood control pressure of blood [22]. pressure [22].InInaddition, addition,Kv Kv channels, whichpromote channels, which promote cell cyclecell progression, are involved cycle progression, in physiological are involved and neoplastic in physiological cell cell and neoplastic growth. Many growth. Many channels channelsare areunder under tight control during proliferation, as they can control carcinogenesis or can be remodeled because of cancer [1–3]. Thus, the final fate of these channels may result in aberrant function, which identifies these proteins either as the origin or as markers of carcinogenesis. During cell cycle regulation, Kv7.1 and Kv7.5 are essential for the cardiovascular system. Therefore, understanding channel physiology and expression are vital for understanding neoplastic remodeling and adaptation in vascular tumors. Here, we revealed that Kv7.1 and Kv7.5 are remodeled during blood vessel Int. J. Mol. Sci. 2020, 21, 6019 9 of 13 tight control during proliferation, as they can control carcinogenesis or can be remodeled because of cancer [1–3]. Thus, the final fate of these channels may result in aberrant function, which identifies these proteins either as the origin or as markers of carcinogenesis. During cell cycle regulation, Kv7.1 and Kv7.5 are essential for the cardiovascular system. Therefore, understanding channel physiology and expression are vital for understanding neoplastic remodeling and adaptation in vascular tumors. Here, we revealed that Kv7.1 and Kv7.5 are remodeled during blood vessel carcinogenesis. The well-structured layered composition of veins and arteries switched to a heterogeneous and amorphous endothelial-derived tumoral mass containing vessels with no layer structure and undefined transportation functions. Under these circumstances, Kv7.1 and Kv7.5 tend to exhibit decreased expression in tumors. Furthermore, the malignancy of the tumor correlated with Kv expression. This could have two alternative implications when considering these proteins for cancer detection and prevention: (i) Kv7 channels are no longer needed to control the vascular tone in indolent tumors because healthy blood vessels disappear or, as previously demonstrated, (ii) Kv7.1 and Kv7.5 play a role in the cell cycle progression of muscle cells [18]. Therefore, highly proliferative cancer cells maintain active channels that help tumor cells survive and divide. The physiological relevance of Kv7 channels is such that alterations in channel expression trigger major diseases [23]. Thus, dysregulation of cardiac Kv7.1, often related to a gain-of-function phenotype, triggers long QT syndrome 1 [24]. In addition, defects in surface targeting of Kv7.2 or Kv7.3 are responsible for neuronal disorders such as epilepsy [25]. Finally, Kv7.5 mutations are also related to epileptic encephalopathy or intellectual disability [26]. In this scenario, cancer also alters the expression of Kv7 isoforms. In the present work, we show for the first time that the expression of Kv7 channels is remodeled in vascular cancer. Kv7.1 and Kv7.5 channels are expressed not only in vascular smooth muscle cells but also in the endothelial lining of human veins and arteries; thus, they may exert a role in endothelial-derived cancers. Vascular tumors, however, lack muscle layers, thus losing the contraction ability. Therefore, if Kv channels are found in these cancers, we expect them to perform a different role, probably related to proliferation or cell survival, instead of regulating vascular tone. Since ion channel research in cancer started more than 40 years ago, many channels have been studied. However, Kv7 channels have received little attention. In this scenario, colon cancer was found to express elevated Kv7.1 levels, and thromboxane A2-induced proliferation increased Kv7.1 abundance [15]. Similarly, lung adenocarcinoma cells augment Kv7.1 expression and, by blocking channel activity, arrest in the G0/G1 phase of the cell cycle [17]. This result is consistent with the antiproliferative effect of linopirdine, a Kv7.5 inhibitor, on myoblast proliferation [18]. However, canine osteosarcoma cell proliferation decreases the expression of Kv7.5 [19]. Furthermore, tamoxifen, which efficiently inhibits Kv7.2/Kv7.3 activity, is used in breast cancer therapy [27]. All this evidence suggests that Kv7 channels are remodeled by cancer, mostly through increasing their expression. Our data are in agreement with this evidence, which indicates that indolent tumors express less Kv7.1 and Kv7.5 than their malignant counterparts. However, the heterogeneity found by these few studies suggests further work is warranted. Kv7.1 and Kv7.5 associate in vascular muscle, and their relative expression differs among different types of vessels [14]. This heterogeneity can modulate the stoichiometry of the tetramer, probably leading to different functional properties of the complex. Although Kv7.1 concomitantly decreased with the indolence of the tumor, some cases presented a variable phenotype. A particular cavernous angioma specimen showed no changes in expression, affecting the overall conclusions. Furthermore, angiosarcoma biopsies, although presenting an elevated MI, exhibited a low TN Kv7.1 ratio. Kv7.5 expression correlated with malignancy. Kv7.5 participates in myoblast proliferation [18], and a higher proliferation in sarcomas and angiosarcomas is concomitant with a higher expression of Kv7.5. In contrast, downregulation of the channel could slow tumor progression, and pharmacological inhibition of Kv7.5 could halt proliferation. Kv channels are considered potential biomarkers and targets for antitumor therapies. We demonstrated that Kv7 channels, which are essential for controlling vascular tone and are implicated Int. J. Mol. Sci. 2020, 21, 6019 10 of 13 in muscle cell proliferation, are expressed in endothelial cells and remodeled in tumor-associated vascular endothelial cancers. Our data suggest that there is good correlation between the level of channel expression and the malignancy of the tumor. Therefore, our work further supports ion channels as potential therapeutic targets in malignant vascular tumors. 4. Materials and Methods 4.1. Tissue Samples, Protein Extraction and Western Blot All animal procedures were approved by the Ethics Committee of the University of Barcelona (86/609/EEC). Human protocols were approved by the ethics committee of the Catalan Institute of Oncology (Hospital Universitari de Bellvitge, PR074/11). Biopsies, deposited at the Banc de Teixits de l’Hospital Universitari de Bellvitge, required no further informed consent to use archived tumor samples. Fresh rat tissues (heart, brain, and quadriceps) and human blood vessel (aorta, cava arteries and carotid and subclavian veins) biopsies were frozen in liquid nitrogen embedded in optimal cutting temperature compound (OCT). Prior to protein extraction, stock pieces were thawed in a saline solution. Tissue (250–500 mg) was cut and gently homogenized in 5 mL HES (20 mM HEPES ((4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 1 mM EDTA (ethylene diamine tetraacetic acid), and 255 mM sucrose, pH 7.4) with protease inhibitors using a Polytron® homogenizer. Nuclei and debris were removed by centrifugation at 15,000× g for 20 min at 4 ◦ C. Supernatants were rehomogenized following the same procedure. Samples were incubated for 30 min at 4 ◦ C and then were centrifuged at 200,000× g for 1.5 h at 4 ◦ C. The supernatant was discarded, and pellet crude membranes were resuspended (0.5 mL/g tissue) in lysis buffer (5 mM EDTA, 5 mM EGTA (ethylene glycol tetraacetic acid), and 1% Triton X-100) with a 25 G needle. Protein concentration was quantified (Bradford, BioRad, Hercules, CA, USA) and frozen until later use. Protein samples (50 mg) were boiled in Laemmli SDS loading buffer and separated on 10% SDS-PAGE gels. Samples were transferred to PVDF (polyvinylidene fluoride) membranes (Immobilon-P, Millipore, Burlington, MA, USA) and blocked in 5% dry milk with 0.05% Tween-20 in PBS (phosphate-buffered saline) before immunoreactions were performed. Membranes were immunoblotted with antibodies against Kv7.1 (1:500, Alomone, Jerusalem, Israel) or Kv7.5 (1:500, Alomone). 4.2. Fluorescence Immunohistochemistry in Human Samples Human tumor and healthy samples were obtained from Banc de Teixits de l’Hospital Universitari de Bellvitge. Nontumor vessels used for this work were carotid arteria, aorta, subclavian vein and inferior cava vein. Tumor samples were from patients (age and sex not provided) with different types of vascular lesions. Paraffin-embedded tumor samples came from 24 cases containing 5 different tumor types (cavernous angioma (5), capillary hemangioma (5), Kaposi’s sarcoma (4), angiosarcoma (4), and glomus tumor (6)). In addition, OCT-embedded frozen samples were provided from 3 specimens and tumor types (cutaneous angiosarcoma (1), teratoma-derived angiosarcoma (1) and epithelioid haemangioendothelioma (1)). All samples were routinely stained with hematoxylin-eosin (HE) and examined by light microscopy. Five-micrometer-thick sections of OCT-embedded frozen tissue samples were placed on poly-L-lysine-coated coverslips and kept at −80 ◦ C until immunolabeling. Sections were fixed in 4% paraformaldehyde with 60 mM sucrose and permeabilized with 0.3% Triton X-100 in PBS-G (20 mM glycine and 0.05% Triton X-100 in PBS). After blocking for 1 h (5% nonfat powder milk, 10% goat serum, and 0.3% Triton X-100 in PBS-G), samples were incubated with anti-Kv7.1 (1:200, Alomone) or anti-Kv7.5 (1:200, Alomone) and anti-α-actin (1:500, Alomone) antibodies. Goat anti-mouse IgG coupled to Alexa Fluor 488 (1:500, Invitrogen, Waltham, MA, USA), goat anti-rabbit IgG coupled to cyanine 3 (1:200, Thermo Fisher Scientific, Waltham, MA, USA) and goat anti-rabbit IgG coupled to cyanine 5 (1:200, Thermo Fisher Scientific) were used as secondary antibodies. Nuclei were Int. J. Mol. Sci. 2020, 21, 6019 11 of 13 counterstained with DAPI (40 ,6-diamidino-2-phenylindole, Sigma, St. Louis, MO, USA). Antigen peptides for Kv7.1 and Kv7.5 (Alomone) were used as negative controls. Five-micrometer-thick sections of paraffin-embedded samples were stored at room temperature until immunolabeling. Sections were deparaffinized and rehydrated by batch-type dipping in solvents. Briefly, samples were subsequently soaked twice in xylene for 5 min, twice in 100% ethanol for 3 min, twice in 95% ethanol for 1 min, once in 70% ethanol for 3 min, once in 30% ethanol for 3 min and, finally, twice in PBS-G for 5 min. No antigen retrieval was required for either Kv7.1 or Kv7.5 staining. The rehydrated sections were immunostained following the abovementioned procedure used for OCT-embedded samples. 4.3. Confocal Scanning Laser Microscopy For confocal sample analysis, two systems were alternatively used after sample preservation. Paraffin embedded samples were imaged under a Leica TCS SP5 II (2 photon) laser-scanning confocal spectral microscope (Leica Microsystems GmbH, Wetzlar, Germany) equipped with an argon multiline laser (458, 488 and 514 nm), a DPSS 561 nm laser and a helium-neon laser (633 nm). To screen the entire sample, Matrix HCS-A Software (Leica), a system that performs high content screening, was used. Briefly, a low magnification (10×) lens was used to take consecutive images of the whole sample size, which were then stitched together to generate a single image. This image was used to identify regions of interest (ROIs), including healthy and tumoral blood vessels. After they were identified, ROIs were individually set as the focal plane to avoid sample thickness variations. By using a high magnification lens (63× oil immersion objective lens (NA 1.32)), a new screening was performed for each ROI, and consecutive images were overlapped to obtain single representations of the area selected. OCT-embedded samples were imaged under an LSM880 Zeiss confocal laser scanning microscope (Carl Zeiss Microscopy, Oberkochen, Germany). The process of image acquisition was similar to that described above, but in this case, no additional software was required, as the software has a function that allows the capture of consecutive images and automatic stitching to generate a single image. In all cases, 10× images were taken at low resolution (256 × 256), 600 Hz speed, bidirectional mode scanning with a pinhole aperture of 2 Airy units at zoom 1. Scanning was performed sequentially for observation of each fluorescent protein by grouping UV and near red in one scan (DAPI and Cy3, 405 nm and 561 nm laser lines, respectively) and green and far red channels in another (Alexa 488 and Cy5, 458 nm and 633 nm line, respectively). 4.4. Histologic Analysis The morphological features of tumor samples were evaluated in hematoxylin-eosin (HE)-stained slides. Mitotic figures were identified morphologically by the condensed “hairy” characteristics of the chromosomes to distinguish prophase, metaphase, anaphase and telophase stages. Mitosis was counted by direct evaluation of 10 high power fields (HPF) by using 400× magnification with a Leica DMIRB Inverted Leica Modulation Contrast Microscope (Leica). HPFs were randomly selected in the tumor area and surrounding regions covering up to a 1 mm2 distance. The total mitotic index was calculated as the ratio between the number of mitotic events and the total cell number per HPF and are represented as the mean percentage. A minimum of 1000 cells were counted from each tumor type. Supplementary Materials: The following are available online at http://www.mdpi.com/1422-0067/21/17/6019/s1. Author Contributions: Conceptualization and experimental design, A.F.; methodology, C.S.-N. and A.O.; validation, A.F., E.C. and J.C.F.; data analysis, C.S.-N. and E.C.; investigation, C.S.-N. and A.O.; sample collection, E.C. and J.C.F.; writing and editing, A.F. All authors have read and agreed to the published version of the manuscript. Funding: This research was funded by Ministerio de Economia y Competitividad (MINECO, Spain) grants (BFU2017-87104-R) and Fondo Europeo de Desarrollo Regional (FEDER). Conflicts of Interest: The authors declare no conflict of interest. Int. J. Mol. Sci. 2020, 21, 6019 12 of 13 References 1. Serrano-Novillo, C.; Capera, J.; Colomer-Molera, M.; Condom, E.; Ferreres, J.C.; Felipe, A. Implication of Voltage-Gated Potassium Channels in Neoplastic Cell Proliferation. Cancers (Basel) 2019, 11, 287. [CrossRef] [PubMed] 2. Kunzelmann, K. Ion channels and cancer. J. Membr. Biol. 2005, 205, 159–173. [CrossRef] [PubMed] 3. Pardo, L.A.; Stuhmer, W. The roles of K(+) channels in cancer. Nat. Rev. Cancer 2014, 14, 39–48. [CrossRef] [PubMed] 4. Felipe, A.; Vicente, R.; Villalonga, N.; Roura-Ferrer, M.; Martinez-Marmol, R.; Sole, L.; Ferreres, J.C.; Condom, E. Potassium channels: New targets in cancer therapy. Cancer Detect. Prev. 2006, 30, 375–385. [CrossRef] 5. Bell, C.D. Endothelial cell tumors. Microsc. Res. Tech. 2003, 60, 165–170. [CrossRef] 6. Sepulveda, A.; Buchanan, E.P. Vascular tumors. Semin. Plast. Surg. 2014, 28, 49–57. [CrossRef] 7. Fosmo, A.L.; Skraastad, O.B. The Kv7 Channel and Cardiovascular Risk Factors. Front. Cardiovasc. Med. 2017, 4, 75. [CrossRef] 8. Brueggemann, L.I.; Moran, C.J.; Barakat, J.A.; Yeh, J.Z.; Cribbs, L.L.; Byron, K.L. Vasopressin stimulates action potential firing by protein kinase C-dependent inhibition of KCNQ5 in A7r5 rat aortic smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2007, 292, H1352–H1363. [CrossRef] 9. Chadha, P.S.; Jepps, T.A.; Carr, G.; Stott, J.B.; Zhu, H.L.; Cole, W.C.; Greenwood, I.A. Contribution of kv7.4/kv7.5 heteromers to intrinsic and calcitonin gene-related peptide-induced cerebral reactivity. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 887–893. [CrossRef] 10. Byron, K.L.; Brueggemann, L.I. Kv7 potassium channels as signal transduction intermediates in the control of microvascular tone. Microcirculation 2018, 25. [CrossRef] 11. Yeung, S.Y.; Greenwood, I.A. Electrophysiological and functional effects of the KCNQ channel blocker XE991 on murine portal vein smooth muscle cells. Br. J. Pharmacol. 2005, 146, 585–595. [CrossRef] [PubMed] 12. Ng, F.L.; Davis, A.J.; Jepps, T.A.; Harhun, M.I.; Yeung, S.Y.; Wan, A.; Reddy, M.; Melville, D.; Nardi, A.; Khong, T.K.; et al. Expression and function of the K+ channel KCNQ genes in human arteries. Br. J. Pharmacol. 2011, 162, 42–53. [CrossRef] [PubMed] 13. Haick, J.M.; Byron, K.L. Novel treatment strategies for smooth muscle disorders: Targeting Kv7 potassium channels. Pharmacol. Ther. 2016, 165, 14–25. [CrossRef] [PubMed] 14. Oliveras, A.; Roura-Ferrer, M.; Sole, L.; de la Cruz, A.; Prieto, A.; Etxebarria, A.; Manils, J.; Morales-Cano, D.; Condom, E.; Soler, C.; et al. Functional assembly of Kv7.1/Kv7.5 channels with emerging properties on vascular muscle physiology. Arterioscler. Thromb. Vasc. Biol. 2014, 34, 1522–1530. [CrossRef] [PubMed] 15. Shimizu, T.; Fujii, T.; Takahashi, Y.; Suzuki, T.; Ukai, M.; Tauchi, K.; Horikawa, N.; Tsukada, K.; Sakai, H. Up-regulation of Kv7.1 channels in thromboxane A2-induced colonic cancer cell proliferation. Pflugers Arch. 2014, 466, 541–548. [CrossRef] 16. Tsevi, I.; Vicente, R.; Grande, M.; Lopez-Iglesias, C.; Figueras, A.; Capella, G.; Condom, E.; Felipe, A. KCNQ1/KCNE1 channels during germ-cell differentiation in the rat: Expression associated with testis pathologies. J. Cell. Physiol. 2005, 202, 400–410. [CrossRef] [PubMed] 17. Ren, K.; Xu, R.; Huang, J.; Zhao, J.; Shi, W. Knockdown of long non-coding RNA KCNQ1OT1 depressed chemoresistance to paclitaxel in lung adenocarcinoma. Cancer Chemother. Pharm. 2017, 80, 243–250. [CrossRef] 18. Roura-Ferrer, M.; Sole, L.; Martinez-Marmol, R.; Villalonga, N.; Felipe, A. Skeletal muscle Kv7 (KCNQ) channels in myoblast differentiation and proliferation. Biochem. Biophys. Res. Commun. 2008, 369, 1094–1097. [CrossRef] 19. Lee, B.H.; Ryu, P.D.; Lee, S.Y. Serum starvation-induced voltage-gated potassium channel Kv7.5 expression and its regulation by Sp1 in canine osteosarcoma cells. Int. J. Mol. Sci. 2014, 15, 977–993. [CrossRef] 20. WHO Classification of tumours. In Soft Tissue and Bone Tumours, 5th ed.; International Agency for Research on Cancer (IARC): Lyon, France, 2019; Volume 3. 21. Abbott, G.W. KCNQs: Ligand- and Voltage-Gated Potassium Channels. Front. Physiol. 2020, 11, 583. [CrossRef] 22. Greenwood, I.A.; Ohya, S. New tricks for old dogs: KCNQ expression and role in smooth muscle. Br. J. Pharmacol. 2009, 156, 1196–1203. [CrossRef] [PubMed] Int. J. Mol. Sci. 2020, 21, 6019 13 of 13 23. Barrese, V.; Stott, J.B.; Greenwood, I.A. KCNQ-Encoded Potassium Channels as Therapeutic Targets. Annu. Rev. Pharmacol. Toxicol. 2018, 58, 625–648. [CrossRef] [PubMed] 24. Krumerman, A.; Gao, X.; Bian, J.S.; Melman, Y.F.; Kagan, A.; McDonald, T.V. An LQT mutant minK alters KvLQT1 trafficking. Am. J. Physiol. Cell Physiol. 2004, 286, C1453–C1463. [CrossRef] 25. Greene, D.L.; Hoshi, N. Modulation of Kv7 channels and excitability in the brain. Cell. Mol. Life Sci. 2017, 74, 495–508. [CrossRef] [PubMed] 26. Lehman, A.; Thouta, S.; Mancini, G.M.S.; Naidu, S.; van Slegtenhorst, M.; McWalter, K.; Person, R.; Mwenifumbo, J.; Salvarinova, R.; Guella, I.; et al. Loss-of-Function and Gain-of-Function Mutations in KCNQ5 Cause Intellectual Disability or Epileptic Encephalopathy. Am. J. Hum. Genet. 2017, 101, 65–74. [CrossRef] [PubMed] 27. Ferrer, T.; Arechiga-Figueroa, I.A.; Shapiro, M.S.; Tristani-Firouzi, M.; Sanchez-Chapula, J.A. Tamoxifen inhibition of kv7.2/kv7.3 channels. PLoS ONE 2013, 8, e76085. [CrossRef] © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).